ura Oncology Inc., a clinical stage biopharmaceutical company that develops therapies for cancer patients, is now trading on the NASDAQ after an initial public offering. The technology behind the company comes from researchers at the University of Michigan Medical School, and others.
Right now, in any American hospital, about half of the patients have a prescription for an acid-reducing drug to reduce heartburn or prevent bleeding in their stomach and gut. But that well-intentioned drug may actually boost their risk of dying during their hospital stay, a new study finds – by opening them up to infections that pose more risk than bleeding would.
When it comes to preventing stroke, millions of Americans with irregular heartbeats face a choice: Take one of the powerful but pricey new pills they see advertised on TV, or a much cheaper 60-year-old drug that can be a hassle to take, and doesn’t prevent stroke as well. It doesn’t seem like much of a contest -- until you do the math.
f you don’t have health insurance, or your insurance coverage still leaves you with big bills, hospitals are supposed to let you know if you qualify for free or reduced-price care, and to charge you fairly even if you don’t, if they want to keep their tax-free nonprofit status. But a new study finds many nonprofit hospitals have room to improve.
Anyone who takes medicine to get their blood sugar or blood pressure down – or both – knows their doctor prescribed it to help them. But what if stopping, or at least cutting back on, such drugs could help even more? Two new studies explore how often doctors use this option.
A new study from the University of Michigan Comprehensive Cancer Center reveals molecular changes within a tumor that are preventing immunotherapy drugs from killing off the cancer. It explains why not all patients respond to immunotherapy treatments.
U-M experts in cancer biology, emergency heart care, bone biology and chronic disease care are among the new members of the National Academy of Medicine of the National Academies, one of the highest honors in the fields of health and medicine.
Brain tumor tissue can be hard to distinguish from normal brain during surgery. Neurosurgeons use their best judgment in the operating room but often must guess exactly where the edges of the tumor are while removing it. Now, a laser-based microscopic technology may help surgeons see the difference between tumor tissue and normal brain in real-time.
You might not see a tiny University of Michigan “block M” logo on the drugs, devices and methods your doctors use in the future. But new ideas and technology developed at U-M may very well be behind the care you get.
When it comes to treating depression, how well a person responds to a fake medicine may determine how well they’ll respond to a real one, new research finds. Those who can muster their brain’s own chemical forces against depression, it appears, have a head start in overcoming its symptoms with help from a medication.
The results of a five-year trial from faculty at the University of Michigan Injury Center found giving youth in the emergency department a short intervention during their visit decreased their alcohol consumption and problems related to drinking over the following year.
When an older person gets hospitalized for pneumonia, where’s the best place to care for them? New research findings about deaths and health care costs in such patients fly in the face of conventional wisdom – and could change where doctors decide to treat them. Seniors with this common lung infection, the researchers show, had a better chance of surviving if they went to an intensive care unit rather than a general hospital bed.
The University of Michigan Health System – which includes three hospitals, the health centers, many basic science research departments and the UM Medical School – will be further integrated under a strategic approach outlined today to strengthen the university’s three-part health care mission of patient care, research and education.
More than a billion times a year, doctors and nurses insert tiny tubes into the veins of American hospital patients, so they can deliver lifesaving medicines, give fluids and nutrition, monitor key vital signs, and help patients with conditions ranging from cancer and pain to kidney failure and serious infections. Now, a U-M-led effort will help them choose the best device for each patient.
A health insurance model designed to improve care and cut costs — a concept that grew out of a decade of work at the University of Michigan — will be tested in seven states, according to an announcement today from the Centers for Medicare & Medicaid Services (CMS).
The Centers for Medicare & Medicaid Services has issued results showing that the Medicare Accountable Care Organizations (ACO) that includes all UMHS physicians continues to generate financial savings while improving the quality of care for Medicare beneficiaries by fostering greater collaboration between doctors, hospitals, and health care providers.